Brought to you by 
Akili brings in $30.5mm through Series B round; later adds on $11.9mm
10 Sep 2018
Executive Summary
Digital medicine company Akili Interactive Labs Inc. (software-based treatments for cognitive disorders) closed a $30.5mm Series B round with participation from Jazz Venture Partners, Canepa Advanced Healthcare Fund, and PureTech Health.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Akili brings in $30.5mm through Series B round; later adds on $11.9mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice